Budesonide NDC 69842-001

NDC codes

FDA NDC Directory

Product NDC (as listed)69842-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69842-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69842-001-01	69842000101	1 BOTTLE, SPRAY in 1 BOTTLE, SPRAY (69842-001-01) / 120 SPRAY, METERED in 1 BOTTLE, SPRAYMarketed from Jul 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Budesonide
Generic name (nonproprietary): budesonide
Active ingredients: Budesonide — 32 ug/1
Dosage form: Spray, Metered
Route: Nasal
Labeler: CVS Pharmacy
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078949
Marketing start: Jul 1, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 69842-001_e78eb875-a802-43b8-8672-cbde17e9b607SPL ID e78eb875-a802-43b8-8672-cbde17e9b607SPL set ID b2650d29-c011-48f1-a7f4-040011d4563dRxCUI 1797929UNII Q3OKS62Q6X
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469842000101 followed by a unit qualifier and the quantity

Package 69842-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 21, 2026.

Indications (excerpt from the label)

Use s Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion runny nose itchy nose sneezing

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078949

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078949
Product	Strength	Form · route	Labeler	Product NDC
Budesonide	Budesonide 32 ug/1	Spray, MeteredNasal	Rugby Laboratories	0536-1112
Budesonide	Budesonide 32 ug/1	Spray, MeteredNasal	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	49035-703
Budesonide	Budesonide 32 ug/1	Spray, MeteredNasal	Walgreens	0363-0048
Budesonide	Budesonide 32 ug/1	Spray, MeteredNasal	Rugby Laboratories	0536-1456
Budesonide	Budesonide 32 ug/1	Spray, MeteredNasal	Apotex Corp.	60505-6129